ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
149 hedge funds and large institutions have $327M invested in Achillion Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $480M → $327M (-$153M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
149
Holding in Top 10
2
Calls
$983K
Puts
$617K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$12.4M | |
| 3 | +$5.3M | |
| 4 |
BlackRock
New York
|
+$5M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$4.63M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$14.1M | |
| 3 | -$8.61M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.27M |
| 5 |
AC
Armistice Capital
New York
|
-$4.58M |